Metronomia News

What’s up at METRONOMIA? Check out our news archive and read about our latest plans, events, milestones or key people.

Global 24/7 helpdesk services

From today Metronomia is able to provide global 24/7 helpdesk services in eCRF studies.

Read more …

New version of IWRS released

We are proud to announce that a new version of our in-house developed interactive web response system was released last month.  

Read more …

First US site initiated

The first US site ever was activated for using an eCRF provided by Metronomia in a multinational phase II leukemia trial. 

Read more …

All the best for 2012!

Metronomia wishes you - our customers, partners and visitors - a prosperous and Happy New Year 2012.
We are looking forward to continuing our successfull collaboration in 2012.

Read more …

25.11.2011: Application of propensity score based matching in oncology

Today Metronomia has delivered the statistical report for an indirect comparison of data from a single arm trial in oncology with a historical dataset based on ...  

Read more …

23.11.2011: Critical market access trial in COPD awarded to Metronomia

Today a multinational pharmaceutical customer awarded a critical  market access trial in COPD to Metronomia.

Read more …

12.08.2011: Business Development- eCRFs outperforms paper-CRFs

It' the first time that we at Metronomia see more eCRF project being abwarded to Metronomia than paper-CRF trials. 

Read more …

05.07.2011: Metronomia Social Day

On the 5th of July, Metronomia spent a day working in an asylum-seekers' hostel in Munich.

Read more …

Meet us at the European Clinical Data Forum!

Metronomia is sponsoring the "European Clinical Data Forum", 24 - 25 May 2011 in Munich, Germany.This event bundles two conferences: "eClinical Trials" and "Clinical Data Management", both representing Metronomia’s core business. We are looking forward to welcome you at our booth!

Read more about this event: http://www.arena-international.com

Read more …

Study with innovative stem cell therapy in PAOD initiated in March 2001

Metronomia is providing monitoring, data management and statistical services for a randomized phase II study with innovative stem cell therapy in patients suffering from peripheral arterial occlusive disease. 

Read more …